Plato Investment Management Ltd

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1984475 SYDNEY, C3

Position in ALNY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,105,081

-$962,525 QoQ

Shares Held

3,671

-41.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#387

of 784 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Plato Investment Management Ltd holds $8,720,382 across 6 Biotechnology names. ALNY ranks #4 (12.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,083	$3,021,608
2	REGN	Regeneron Pharmaceuticals, Inc.	3,983	$2,483,559
3	INCY	Incyte Corp	14,856	$1,684,076
4	ALNY	Alnylam Pharmaceuticals, Inc. This page	3,671	$1,105,081
5	EXEL	Exelixis, Inc.	5,702	$310,245
6	BMRN	Biomarin Pharmaceutical Inc	2,024	$115,813

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,105,081	3,671	-41.3%	Shares	Sole	2026-08-07
2026-03-31	$2,067,606	6,249	-0.1%	Shares	Sole	2026-05-05
2025-12-31	$2,486,903	6,254	+27.5%	Shares	Sole	2026-02-04
2025-09-30	$2,237,136	4,906	+19.3%	Shares	Sole	2025-11-05
2025-06-30	$1,341,208	4,113	-11.7%	Shares	Sole	2025-08-05
2025-03-31	$1,258,023	4,659	-16.0%	Shares	Sole	2025-05-20
2024-12-31	$1,305,264	5,547	+18.0%	Shares	Sole	2025-02-06
2024-09-30	$1,293,191	4,702	+33.2%	Shares	Sole	2024-11-06
2024-06-30	$857,547	3,529	-21.7%	Shares	Sole	2024-08-09
2024-03-31	$673,870	4,509	+2666.3%	Shares	Sole	2024-05-17
2023-12-31	$31,199	163	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.